Morgan Joseph initiates coverage on Genzyme (Nasdaq: GENZ) with a Buy rating and an $81 price target.

Morgan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE